Wednesday, May 12, 2021

Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry May 3rd - May 7th, 2021

Investorideas.com - Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry May 3rd - May 7th, 2021

#Crypto and #Cannabis Combine: Global Cannabis Applications Corp. (CSE: $APP.C) (FSE: 2FA) (OTCQB: $FUAPF) CEO Breaks Down Company's Uniswap Token and Efixii Deal with Herb Industries Ltd. @CitizenGreenWld

#Crypto and #Cannabis Combine: Global Cannabis Applications Corp. (CSE: $APP.C) (FSE: 2FA) (OTCQB: $FUAPF) CEO Breaks Down Company's Uniswap Token and Efixii Deal with Herb Industries Ltd. @CitizenGreenWld  

 

Point Roberts, WA, Delta BC-May 11, 2021 -  Investorideas.com, a leader in crypto and blockchain investing news brings you today’s special edition of the Crypto Corner podcast  featuring an exclusive interview with Brad Moore, CEO of Global Cannabis Applications Corp. (GCAC) (CSE:APP) (FSE:2FA) (OTCQB:FUAPF). Mr. Moore discusses his company’s use of blockchain and decentralized finance (DeFi) in the medical cannabis space.

 

Global Cannabis Applications Corp, (“GCAC”) is a global leader in designing, developing, SaaS licensing and acquiring innovative blockchain data technologies for the medical cannabis industry.

 

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2021/042821-CryptoMarket.mp3

 

Read this in full at https://www.investorideas.com/news/2021/crypto-corner/05121CSE-APP-Herb-Industries-Ltd.asp

 

Get the Crypto Corner Podcast on iTunes

Get the Crypto corner on Spotify

 

From the interview:

“This is a form of end-user marketing to that market segment that uses both medical cannabis and decentralized finance,” Moore said.

 

A recent press release announced launch of the GCAC token on Uniswap on the Ethereum (ETH) blockchain.  The token was built and is operated by Abbey Technology, a Uniswap-based DeFi service provider. Moore pointed out that GCAC’s relationship to the token is through a marketing contract with Abbey.


 

“They created the token, and we engaged in a marketing contract with them to use our name in association with the token,” he said.

 

Moore explained in the press release:

 

“First and foremost, We - Are - Blockchain. So, I’m delighted to expand our marketing reach to fellow blockchain proponents. Cannabis consumers come in many forms and I am really excited to be marketing directly to the Uniswap DeFi community and raising awareness of cannabis efficacy and quality amongst this rather liquid demographic.”

 

A key feature of the token is GCAC’s commitment to purchase GCAC tokens on Uniswap with one percent of its quarterly revenues.

 

“What’s interesting, as part of our marketing contract, is that we committed to invest one percent of our top-line revenue,” Moore said. “That’s why when you look at next year’s deal with Herb Industries, it has the potential to add $160,000 into the liquidity pool.”

 

“The whole idea is that we’re investing our hard-earned dollars into the liquidity pool in a buyback, so actually, people can see us putting money into the program and as the company grows, it legitimizes what that token actually means.”

 

The deal with the Malta-based Herb Industries Ltd. was announced in a press release on April 13, 2021 and involves a definitive three-year software licensing agreement wherein GCAC will license its Citizen Green Efixii platform as part of the former’s “‘technology farm’ for use in its cannabis compliance and consumer transparency.” Efixii is an app that tracks the full cycle of cannabis cultivations, represented by a QR code.

 

“With cannabis, because it’s such a complex plant, you actually have to measure it on a per gram basis of consumption,” Moore said. “So think about that. All the data points from it growing; all the way through cultivation, all the way through testing, all the way through manufacturing – if it’s going into an edible or into an oil-based product – and all the way to consumption. And then we measure your experience with the Efixii app … and put that on the blockchain. Now we’re getting to the point where we’ve got consumption, on a per gram basis, overlaid with thousands of other people.”

 

Moore explained the utility of the data that the company accrues can be leveraged by regulators.

 

“Once you get big data like that, you can do some interesting things,” he said. “Most importantly, a regulator – when there’s a lack of data – can look at that and write meaningful regulations. We’re actually doing this project on behalf of consumers, for the whole point of regulators being able to get behind this and see what a working blockchain can actually do.”

 

About Global Cannabis Applications Corp. “GCAC”

GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.

 

For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange's website www.thecse.com.

 

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

 

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure:  Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. This podcast distribution featuring Global Cannabis Applications Corp. was a paid for service on Investorideas.com (2000) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release  and our content services including tag articles and podcasts and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

 

Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories

 

 

 

 

Tuesday, May 11, 2021

Investor Ideas #Potcasts 563, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (TSXV: $KHRN.V) (OTCQX: $KHRNF), (CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $DELC.C) (OTCQB: $DELCF), (OTC: $MJNA)

 



 

Investor Ideas #Potcasts 563, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (TSXV: $KHRN.V) (OTCQX: $KHRNF), (CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $DELC.C) (OTCQB: $DELCF), (OTC: $MJNA)

 

Delta, Kelowna, BC, May 11, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/051121-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/05111XTRX-KHRN-CURA-DELC-MJNA.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

In today’s podcast we look at a few public company announcements.

 

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal "Psychopharmacology" of the first findings arising from Project Twenty 21, UK's first and largest national medical cannabis registry that was launched on November 7, 2019 at the Royal College of Psychiatrists in London.

 

Through Project Twenty21, eligible patients can access affordable medical cannabis treatment, monitored by Drug Science, UK's leading independent scientific body. The project aims to create the UK's largest body of evidence for the effectiveness and tolerability of medical cannabis to warrant NHS funding where the benefits of treatment with medical cannabis are proven to outweigh the potential risks.

 

The Project Twenty 21 study has now licensed prescriptions of medical cannabis to over 900 patients who are in substantially poorer health than the general population, and who have been unable to manage their diagnosed conditions with commonly prescribed medicines.  The findings show that legally prescribed cannabis provides clinically significant improvements in the quality of life of patients living with conditions such as Chronic Pain, Multiple Sclerosis, Tourette's Syndrome, Epilepsy and Post Traumatic Stress Disorder (PTSD). Based on the early positive momentum of the Project Twety21, Khiron will be launching other commercial initiatives to reach as many people as possible in the country.

 

The patient data collected show that medical cannabis improves the quality of life more than classical treatments do, for example for neuropathic pain. According to the National Institute for Clinical Excellence (NICE), there is little or no evidence that commonly prescribed drugs, such as benzodiazepines or opioids, make any difference to people's quality of life, pain or psychological distress, but they can cause harm, including possible addiction. In contrast, the results of Project Twenty21 clearly show a fifty percent increase in patients' self-reported health and ability to lead a more normal life as well as significant improvements in patients' ability to manage debilitating secondary conditions such as anxiety, insomnia and depression. Also, patients are now able to avoid criminality with legal prescriptions, as many have felt compelled to turn to illegal use to manage their conditions.

 

Project leader of Twenty21 Professor David Nutt from Drug Science, comments: "A lack of clinical evidence has made it difficult for doctors to confidently prescribe legal medical cannabis in the UK. These new findings provide a major step forward and help to clarify the benefit these medicines can have for thousands of seriously ill patients."

 

Tejinder Virk, President of Khiron Europe, says: "We are glad to see our strong commitment with medical research bear its fruits with this publication. Khiron is a true pioneer in the medical cannabis landscape in the UK, and not just because of its products. Our biggest contribution to improve access to medical cannabis in the UK is our education programs for prescribing clinicians and the dissemination of our expertise with cannabis-based therapeutics. We plan to continue our data-driven approach with the deployment of EU-GMP cannabinoid-based medicines based on our Colombian extracts, whose efficacy and safety are backed by clinical data collected in our wholly-owned clinics with over 17,000 prescriptions."

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading international provider of consumer products in cannabis, today announced that wholly owned Curaleaf International subsidiary Adven GmbH ("Adven") has launched its own range of medical cannabis products in Germany, Europe's largest medical cannabis market.  The initial launch of a high THC oil product aims to meet immediate patient demand and will be extended over the course of the year to incorporate a number of different strengths and THC/CBD formulations in both oil and flower formats, addressing a wide range of patient needs. Germany is Europe's largest medical cannabis market and is expected to be worth US$2.1 billion by 2025.

 

Antonio Costanzo, CEO of Curaleaf International, said, "We are very pleased to bring our first medical cannabis products to market in Germany and, with the rapid extension of our product range in 2021, establishing ourselves as a leader in Europe's largest medical cannabis market. Curaleaf International's European supply chain, from cultivation to product research and development and EU-GMP manufacturing processes across Europe, means we are able to guarantee a consistency of product and price to clinicians and patients in need of the highest quality medical cannabis."

 

Julian Vaterrodt, Managing Director, Adven GmbH, added, "German patients and practitioners are increasingly demanding high-quality, consistent and reliable European natural alternatives to help manage a wide range of complaints.  Adven is committed to providing a differentiated product and service for the German market. We focus on providing a consistent supply of high-quality European medical cannabis and cutting-edge digital technologies to improve the patient and healthcare professional experience."

 

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) a psychedelic wellness platform, announced that its acquisition target (under binding letter agreement see news release dated February 4, 2021), Ketamine Infusion Centers ("KIC"), proposes to acquire two (2) additional licensed ketamine clinics in Arizona. The proposed acquisition would double the footprint of the infusion chain and become the largest operator in the state of Arizona.

 

"This is a major step toward becoming the largest ketamine clinic operator in the country, bringing superior quality and expanding access for patients," said Matt Stang, Delic CEO and co-founder. "KIC is the leading name in high quality care and incredible outcomes for its patients and this move helps grow that reputation significantly. As a vital part of the Delic platform, KIC will continue to offer wellness and benefits for many people suffering from anxiety, depression and PTSD."

 

Over the past three years, the team at KIC has expanded from Arizona to California, while overseeing 4,000 treatments administered to date, and generating more than $1.5-million (U.S.) in revenue. KIC continues to operate under the Delic umbrella, under the direction and guidance of Dr. Christopher Ray, Sonny Diaz, Rogelio Monzon and Ganesh Acharya. With the successful completion of the acquisition, KIC will expand to 3 clinics in Arizona, with locations in Central Phoenix, East Valley, and West Valley, and 1 in California, with a location in Bakersfield.

 

Sonny Diaz, co-founder of KIC, stated: "We are thrilled to join the Delic family and double our footprint with this acquisition, allowing greater access to patients for these vital services. Ketamine Infusion Centers unique model and passion to obtain the highest patient outcomes and purely evidence-based practices is a perfect fit in the Delic ecosystem. Together with their vast knowledge of psychedelic wellness, strong partner channels and mission to bring psychedelic wellness into the mainstream, we see unlimited potential of how many lives we may positively affect together."

 

As part of these two sublease transactions, KIC will assume ownership of both licences, which contain the OTC licenses for the respective locations at no additional costs. KIC will submit the necessary paperwork to the State of Arizona to complete the license transfer processes.

 

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil had its best revenue month ever in Company history in April 2021.

 

“Our HempMeds Brasil operations have seen a consistent increase over the years. We aim to reach as many consumers in need as possible and last month’s achievements prove that we are continuing to expand our reach to our target audiences,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

 

“I am incredibly proud of the success our HempMeds Brasil team has been able to achieve. As we celebrate our best revenue month in company history, we are scaling our operations in the country, refreshing our consumer-facing website and increasing the size of our facilities in Brazil to meet the needs of our expanding team,” said HempMeds® CEO Raul Elizalde.

 

“In the coming months, to support our continued growth, we intend to partner with the largest higher education institution in Brazil to educate medical professionals on the potential benefits of cannabidiol (CBD) and are moving forward in securing partnerships with well-respected professional and Olympic athletes,” said HempMeds® Brasil Managing Director Matheus Patelli. “My team has successfully been able to show Brazilian citizens that our products are of the highest quality and trustworthy, just like the people who work at the Company.”

 

Once again, today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Monday, May 10, 2021

Investor Ideas #Potcasts 562, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (NASDAQ: $VFF) (TSX: $VFF.TO), (CSE: $TRUL.C) (OTC: $TCNNF)

 



 

Investor Ideas #Potcasts 562, #Cannabis News and #Stocks on the Move; (CSE: $XTRX.C), (NASDAQ: $VFF) (TSX: $VFF.TO), (CSE: $TRUL.C) (OTC: $TCNNF)

 

Delta, Kelowna, BC, May 10, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/051021-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/05101XTRX-VFF-TRUL.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

Today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

In today’s podcast we look at a few public company announcements.

 

Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFFtoday announced its financial results for the first quarter ended March 31, 2021.  All figures are in U.S. dollars unless otherwise indicated.

 

The Company's financial statements for the three months ended March 31, 2021, as well as the comparative periods for 2020, have been prepared and presented under United States Generally Accepted Accounting Principals ("GAAP"). On March 31, 2021, Village Farms owned 100% of Pure Sunfarms Corp., as the full acquisition of the remaining interest in Pure Sunfarms occurred November 2, 2020.  Accordingly, for the three months ended March 31, 2021, Pure Sunfarms' financial results are consolidated with Village Farms' results.  For the three months ended March 31, 2020, Pure Sunfarms is accounted for on a proportionate basis within "Equity Earnings from Unconsolidated Entities".

 

Pure Sunfarms Highlights Included:

 

       Achieved its third consecutive quarter of sequential growth in its priority sales channel, Retail Branded Sales, of 20% or greater;

       Achieved its tenth consecutive quarter of positive Adjusted EBITDA; and,

       Was the top selling brand of dried flower products with the Ontario Cannabis Store (OCS) (by kilograms sold and dollars sold) for the quarter ended March 31, 2021 and remained the top-selling brand of dried flower products with the OCS (by kilograms sold and dollars sold) since retail branded sales launch in October 2019.

       Produce sales increased 9%, however, Produce Adjusted EBITDA decreased 50% as a result of lower pricing as the tomato industry is experiencing one of the lowest pricing environments for tomatoes-on-the-vine and beefsteak varieties in the past ten years;

       Completed a registered direct offering with certain institutional investors for the purchase and sale of an aggregate of 10,887,097 common shares at a purchase price of US$12.40 (approximately C$15.70) per Common Share for gross proceeds of approximately US$135 million (approximately C$171 million);

       Received warrant exercise proceeds of US$17.7 million resulting in the issuance of 3,045,283 additional common shares. The warrants were issued as part of the September 2020 Registered Direct equity offering. As of the date of this news release, 1,652,830 warrants remain outstanding;

       Repaid in full the C$19.9 million (approximately US$15.6 million) promissory note, plus accrued interest of C$621,534.25 (approximately US$486,849.78), that the Company issued to Emerald Health Therapeutics, Inc. as partial consideration for the November 2020 acquisition of the remaining common shares of Pure Sunfarms that the Company did not own; and,

       Was added to the S&P/TSX Composite Index (Consumer Staples sector) prior to trading on March 22, 2021.

       Increased the equity investment in Altum International Pty Ltd from 6.6% to just under 12% as a capital efficient means to participate in international opportunities in the Asia-Pacific region.

       Village Farms amended the Operating Loan terms to extend the credit agreement with an amended line of credit of C$10,000 and maturity date of May 7, 2024.

 

"The first quarter of 2021 was yet another strong quarter for Pure Sunfarms, which delivered its third consecutive quarter of strong sequential growth in our priority sales channel, Retail Branded Sales – up 20% from the fourth quarter – and is especially encouraging given the softness in the Canadian market due to pandemic restrictions, which stalled sales growth for the rest of the industry," said Michael DeGiglio, CEO, Village Farms. "Our continuing strong momentum was again driven by Pure Sunfarms' leading market share performance in dried flower1 which remains by far the largest product category, with our brand success firmly rooted in our reputation for premium quality products at an everyday price.  This, combined with our best-in-class operations, low-cost production and prudent SG&A management enabled Pure Sunfarms to deliver its tenth consecutive quarter of positive Adjusted EBITDA – every quarter since commencing sales in late 2018."

 

"As we look ahead, our 1.1 million square foot Delta 3 facility is operating at full capacity, and with expected strong growth demand we look forward to significantly expanding our production capacity in the coming months, with plans to increase capacity by 50% by year end and double it in the second half of 2022.  All of this positions Pure Sunfarms – with our existing assets and operations – to meaningfully and sustainably grow its profitability over both the short- and long-terms."

 

"Our continued success and leadership in Canada provide great confidence in our U.S. and international cannabis plans. We continue to monitor the regulatory progress in the U.S. in terms of our opportunity to legally participate in what we believe will be a different market environment that will position experienced, new entrants for success.  We are confident that our unparalleled large-scale, low-cost cultivation capabilities, alongside one of the largest high-tech greenhouse footprints in the country, will provide a meaningful advantage to capitalize on this significant opportunity. We will do so strategically, with prudence and our unwavering commitment to return on investment. In tandem, internationally, we continue to pursue targeted, strategic opportunities for the long-term that, again, meet our thresholds for return on investment."

 

Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF) and Harvest Health & Recreation Inc. (CSE: HARV)(OTCQX: HRVSFannounced that they have entered into a definitive arrangement agreement pursuant to which Trulieve will acquire all of the issued and outstanding subordinate voting shares, multiple voting shares and super voting shares of Harvest. Under the terms of the Arrangement Agreement, shareholders of Harvest will receive 0.1170 of a subordinate voting share of Trulieve for each Harvest subordinate voting share (or equivalent) held, representing total consideration of approximately $2.1 billion based on the closing price of the Trulieve Shares on May 7, 2021.

 

Trulieve, a leading multi-state operator with a focus on the northeast and southeast regions of the United States, and Harvest, a leading multi-state operator with a focus on the west coast and northeast regions of the United States, have built deep, vertically integrated operations in their key markets, becoming leading operators in the United States, the world's largest regulated cannabis market.

 

Upon completion of the Transaction, as well as the closing of other previously announced acquisitions by Harvest and Trulieve, the combined business will have operations in 11 states, comprised of 22 cultivation and processing facilities with a total capacity of 3.1 million square feet, and 126 dispensaries serving both the medical and adult-use recreational cannabis markets.

 

Key Transaction Highlights and Benefits

       Increases Scale Across Our Hub Markets – through the creation of the largest U.S. cannabis operator on a combined retail and cultivation footprint basis;

       Creates the Most Profitable US MSO – with combined 2020 Adjusted EBITDA of $266 million1,2 and combined 2021E consensus Adjusted EBITDA3 of $461 million, delivering an unparalleled platform for continued growth;

       Delivers a Superior Existing Retail and Distribution Model – from a robust retail network of 126 dispensaries across 11 states, the combined company will have leading market shares in Arizona and Florida;

       Strong and Expanding Multi-State Presence – bolsters Trulieve's expansion in US northeast and southeast hubs in Florida, Pennsylvania and Maryland, and establishes a southwest hub in core markets including Arizona, where recreational adult use of cannabis was recently legalized;

       Optimizes Nationwide Presence – through well-established retail and wholesale channels across markets, as well as the ability to reach an estimated total addressable market of US$19.3 billion in 2025E (Arcview market estimate);

       Adds Premium Brands – to Trulieve's portfolio of in-house brands and national brand partners with a successful line of products across multiple form factors;

       Leverages Expert Operating Teams and Best Practices – from each of Trulieve and Harvest, enhancing operational excellence by combining unparalleled knowledge of, and success in winning, state license application processes and the ability to rapidly bring operations to market; and

       Accretive Transaction Reinforces Trulieve's Leading Financial Metrics – by reinforcing superior financial performance relative to peers through industry-leading margins and strong projected profitable growth.

 

"Today's announcement is the largest and most exciting acquisition so far in our industry, creating the most profitable public multi-state operator.  Importantly, our companies share similar customer values with a focus on going deep in core markets. This combination offers us the opportunity to leverage our respective strong foundations and propel us forward with an unparalleled platform for future growth," stated Kim Rivers, Chief Executive Officer of Trulieve. "Harvest provides us with an immediate and significant presence in new and established markets and accelerates our entry into the adult use space in Arizona. Trulieve and Harvest are leaders in our markets, recognized for our innovation, brands, and operational expertise with true depth and scale in our businesses. We look forward to providing best-in-class service to patients and customers on a broader national scale as we create an iconic US cannabis brand."

 

"We are thrilled to be joining Trulieve, a company that has achieved unrivaled success and scale in its home state of Florida," said Steve White, Chief Executive Officer of Harvest.  "As one of the oldest multi-state operators, we believe our track record of identifying and developing attractive market opportunities combined with our recent successful launch of adult use sales in Arizona will add tremendous value to the combined organization as it continues to expand and grow in the coming years."

 

 

OG DNA Genetics, a globally recognized leading cannabis brand, today announced a licensing agreement with UNIVO Pharmaceuticals LTD, an Israeli based medical cannabis company trading on the Tel Aviv stock exchange under the symbol (UNVO.TA).

 

This Agreement will grant UNIVO license to the DNA brand and access to their proprietary library of award-winning genetics (including Kosher Kush) for use at the company’s 5-acre cultivation facility located in the south of Israel.

 

“We’re excited to announce our partnership with UNIVO Pharmaceuticals and our entry into the rapidly developing Israeli medical cannabis market. Through this partnership, we will be able to bring our unique varieties to Israel and develop new and exciting cannabis-derived medicinal products to export internationally. We couldn’t ask for a better partner to enter the Israeli medical cannabis market with than UNIVO Pharmaceuticals,” said Rezwan Khan, President of DNA Genetics.

 

“We are pleased to announce a strategic joint venture with DNA Genetics, a well-known global player in the field of cannabis, who has examined the Israeli market and partnered with us to build a joint international brand. We strongly believe that the technological and marketing capabilities of both companies will result in a high quality and competitive brand that will be launched shortly, which will contribute to our market presence both locally and outside our domestic Israeli market,” said Golan Bitton, CEO of UNIVO Pharmaceuticals.

"We are pleased to partner with DNA Genetics, one of the leading companies in the field of cannabis genetics and farming. Our professional teams will collaborate on Amit Farm to develop new cannabis strains while growing the best genetics and make available the best products using our leading global standard farming infrastructure for the benefit of patients in Israel and other countries," said Omer Layani, Amit Farm Manager.

 

Since its inception, the genetics developed by DNA have won more than 200 awards, in all

categories, at the most prestigious cannabis events around the world – making DNA the global standard in breeding and growing truly best-in-class strains. These awards include the High Times’ Top 10 Strain of the Year, which was inducted into the High Times Seedbank Hall of Fame in 2009, the High Times’ 100 Most Influential People in the Industry, and the High Times’ Trail Blazers Award, for contributions made towards uniting the fields of entrepreneurship, politics, and medicine.

 

Veridocs Inc., a leader in solutions for ID authentication and identity management, announced the introduction of the Veridocs BrightTower Retail Safety and Security System. This affordable, modular system automates the age verification process with technology far more advanced than a barcode scan and can also check internal and external watch lists according to state and local regulations. With ID readers, software, training, and additional options and integrations, BrightTower Retail delivers a flexible tool that outperforms standard ID verification systems and helps cannabis retailers maintain strict compliance.

 

BrightTower Retail’s ID authentication starts when a customer or staff member inserts an ID into the reader. It is quickly compared against a global database to confirm the presence of security features such as UV and other specialized inks, plus other electronic features present in the document. The technology confirms a match between the encoded data (such as barcodes and chips) with the data printed on the front of the document. This helps retailers easily spot barcode forgeries, which are increasingly common on fake IDs.

 

Cannabis retailers also have the option of incorporating watch list checks, automatically comparing the data on the ID document to databases as required by any state and local regulations. An option for facial matching compares the ID photo to a live image of the person presenting the ID, giving staff a useful tool to flag customers “borrowing” an older sibling or friend’s ID. Retailers can also use the technology to keep audit trails of ID scans for future reference and enforcement concerns.

 

BrightTower Retail includes on-demand training modules designed by experts in organizational safety and security. With this training, retailers can easily onboard staff members and help them make the right decisions when a fake ID is flagged, or a security concern arises.

 

Additional options such as security cameras with covert triggers are available for users to add extra layers of protection customized for their environments. BrightTower’s security experts—veterans of safety, security and fraud prevention—are also available for custom consulting and on-site assessments and trainings.

 

“BrightTower Retail was designed to help eliminate staff guesswork in spotting fake or ‘borrowed’ IDs,” Veridocs President and CEO Joe Oprosko said. “We’re giving retailers the tools—in both technology and training—to be certain they’re protecting themselves against fines, possible threats and fraud.”

 


Once again, today’s podcast is sponsored by Phyto Extractions Inc. (CSE:XTRX), an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction, no cultivation), Sales (extracts, topicals, and edibles) through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc. Adastra Labs also has a pending Health Canada R&D license amendment.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Play Music and most audio platforms available.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory